Vincristine
DrugBank ID: DB00541
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| Hodgkins lymphoma | 0.9973 | DL |
| follicular lymphoma | 0.9940 | DL |
| ganglioneuroblastoma (disease) | 0.9931 | DL |
| vertebral anomalies and variable endocrine and T-cell dysfunction | 0.9924 | DL |
| retroperitoneal neoplasm | 0.9923 | DL |
| neuroblastoma | 0.9922 | DL |
| ALK-positive large B-cell lymphoma | 0.9921 | DL |
| acute lymphoblastic/lymphocytic leukemia | 0.9899 | DL |
| AIDS-related primary central nervous system lymphoma | 0.9882 | DL |
| composite lymphoma | 0.9882 | DL |
| nasal cavity lymphoma | 0.9882 | DL |
| ovarian lymphoma | 0.9882 | DL |
| progressive transformation of germinal centers | 0.9882 | DL |
| chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation | 0.9875 | DL |
| pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma | 0.9875 | DL |
| mediastinal malignant lymphoma | 0.9873 | DL |
| ureteral lymphoma | 0.9873 | DL |
| breast lymphoma | 0.9871 | DL |
| lymphoid neoplasm | 0.9867 | DL |
| systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood | 0.9864 | DL |
| primary pulmonary lymphoma | 0.9862 | DL |
| methotrexate-associated lymphoproliferative disorders | 0.9861 | DL |
| pulmonary blastoma | 0.9861 | DL |
| hydroa vacciniforme-like lymphoma | 0.9861 | DL |
| well-differentiated fetal adenocarcinoma of the lung | 0.9858 | DL |
| B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma | 0.9856 | DL |
| tracheal lymphoma | 0.9854 | DL |
| lymphoid hemopathy | 0.9850 | DL |
| Burkitt lymphoma | 0.9847 | DL |
| acute lymphoblastic leukemia (disease) | 0.9846 | DL |
| bladder lymphoma | 0.9846 | DL |
| retroperitoneal lymphoma | 0.9844 | DL |
| small cell lung carcinoma | 0.9843 | DL |
| eye lymphoma | 0.9841 | DL |
| chronic myelogenous leukemia, BCR-ABL1 positive | 0.9837 | DL |
| B-cell neoplasm | 0.9836 | DL |
| neoplasm of mature B-cells | 0.9835 | DL |
| leukemia, lymphocytic, susceptibility to | 0.9833 | DL |
| botryoid-type embryonal rhabdomyosarcoma of the vagina | 0.9831 | DL |
| obsolete Hodgkin's granuloma | 0.9830 | DL |
| primary effusion lymphoma | 0.9822 | DL |
| parameningeal embryonal rhabdomyosarcoma | 0.9821 | DL |
| MALT lymphoma | 0.9818 | DL |
| rhabdomyosarcoma (disease) | 0.9818 | DL |
| embryonal extrahepatic bile duct rhabdomyosarcoma | 0.9818 | DL |
| lung lymphoma | 0.9811 | DL |
| B-cell prolymphocytic leukemia | 0.9806 | DL |
| extrahepatic bile duct rhabdomyosarcoma | 0.9806 | DL |
| prostate embryonal rhabdomyosarcoma | 0.9806 | DL |
| small intestinal Burkitt lymphoma | 0.9805 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.